XM does not provide services to residents of the United States of America.

Norway's Yara seeks antitrust nod for Brazil NPK asset disposal



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>Norway's Yara seeks antitrust nod for Brazil NPK asset disposal</title></head><body>

SAO PAULO, July 11 (Reuters) -Yara YAR.OL is seeking antitrust permission to sell assets and rights related to the production and sale of liquid NPK fertilizers to a local company in Brazil, a move to stay competitive on a key market for the Oslo-based firm.

Yara and privately-owned buyer FassAgro did not immediately reply to a comment request regarding the details of the proposed transaction, which was first reported by newspaper Valor Economico on Thursday and notified to antitrust authority CADE in late June.

The move reflects Yara's strategic repositioning in Brazil, its main market outside of Europe, according to analysts.

Constrained by Western sanctions on big fertilizer suppliers like Russia and Belarus, Yara has been losing market share in the country and plans to focus on the sale and production of products of higher aggregate value, Marcelo Mello, a StoneX analyst, said.

Brazil is heavily dependent on fertilizer imports for blending internally and nourishing crops like soy, corn and sugarcane.

According to import and production data compiled by StoneX, Yara's market share dropped from 18% in 2021 to 11% last year, a trend likely to continue.

Mosaic MOS.N, the largest local player, commanded a 17% share of Brazil's market in 2023 while Yara was overcome by the local arm of Swiss-headquartered Eurochem group, which has Russian origins and now has a 12% share, StoneX data showed.

Regarding the proposed deal with FassAgro, Yara and the buyer told CADE both firms operate in the production and commercialization of NPK fertilizers distributed in liquid form.

However, given neither company has a large share of this segment of the market, the deal would not raise any competition concerns, Yara said, according to public filings.



Reporting by Ana Mano, Editing by Franklin Paul

</body></html>

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.